1910 Genetics
45 employees
AI
Series A · $29.8M
Open positions (6)
Company details
Team Size45
IndustryAI
Funding
Total raised
$29.8M
Last stage
Series A
Investors
Y Combinator
Total raised
$29.8M
Last stage
Series A
Investors
Jen Nwankwo
PhD-holding founder and CEO of 1910 Genetics, leading the company's AI-driven drug discovery platform since its founding in 2018.
LinkedInNo applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.